Research on the Core Competitiveness of Jiangsu Heng Rui

DOI

10.2991/iccesd-19.2019.1How to use a DOI?

Keywords

Core competitiveness; Hengrui medicine; Strategy; Competition

Abstract

The competition among pharmaceutical companies in the future is the competition of the core competitiveness of enterprises. The purpose of this study is to improve the core competitiveness of Jiangsu Hengrui Medicine. Through the macro-environmental analysis of Jiangsu Hengrui's core competitiveness, Porter's five-force model analysis and SWOT analysis, the problems of its core competitiveness are pointed out through the product revenue structure, human resource management, sales channel terminal, and pharmaceutical R&D investment. This study aims to enhance the core competitiveness of Jiangsu Hengrui Medicine from five aspects of intellectual property protection.

Copyright

© 2019, the Authors. Published by Atlantis Press.

Open Access

This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

TY  - CONF
AU  - Mingda Song
PY  - 2019/07
DA  - 2019/07
TI  - Research on the Core Competitiveness of Jiangsu Heng Rui
BT  - Proceedings of the 2019 International Conference on Contemporary Education and Society Development (ICCESD 2019)
PB  - Atlantis Press
SP  - 1
EP  - 4
SN  - 2352-5398
UR  - https://doi.org/10.2991/iccesd-19.2019.1
DO  - 10.2991/iccesd-19.2019.1
ID  - Song2019/07
ER  -